VIEWPOINTS Jonathan Wall, Co-founder & Interim CSO at Attralus Share Insights from its New Data Presented across its Amyloidosis Portfolio at the 2022 International Symposium on AmyloidosisBySenior EditorOctober 17, 20220Comments
EVENTS Exclusive Coverage: Key Takeaways from the 6th Annual Medical Device Regulatory Quality Summit 2022BySenior EditorOctober 14, 20220Comments
TOP 20 Top 20 Generics Pharma Companies Based on 2021 Total RevenueByPrince GiriOctober 13, 20220Comments
VIEWPOINTS Michael Scheffler, Vice President, Head of Life Science PCR at QIAGEN Shares Insights on the Addition of New Biopharma Products to its Digital PCR PortfolioBySenior EditorOctober 12, 20220Comments
THOUGHTSPOT Competitive Intelligence: A Substantial Advantage for the Pharmaceutical SectorBySaurabh ChaubeyOctober 11, 20220Comments
VIEWPOINTS Alex Zimmerman and Alexander Lin Share Insights on the FDA Breakthrough Device Designation Received for Non-Invasive Virtual Biopsy TechnologyBySenior EditorOctober 10, 20220Comments
EVENTS 6th Annual Medical Device Regulatory and Quality Summit 2022BySenior EditorOctober 7, 20220Comments
